Temple publishes first validation study for its wearable brain flow metric

What the study found

Temple’s validation study tested its wearable’s brain flow metric against transcranial Doppler (TCD) ultrasound, a standard method for measuring cerebral blood-flow velocity. According to Inc42, the study involved 23 healthy adults and found broad alignment between Temple’s metric and the ultrasound readings.

The findings were published as a preprint, meaning they have not undergone peer review. The researchers acknowledged that the study does not confirm the metric’s ability to measure absolute cerebral blood flow or its clinical efficacy.

Limitations and next steps

The study’s small sample size and focus on healthy adults limit its applicability to broader populations or clinical settings. Inc42 reports that the researchers emphasized the need for further studies to establish the metric’s cerebral specificity and potential clinical uses.

Temple’s wearable aims to track brain health, a category gaining traction among startups in India and globally. However, the lack of peer review and clinical validation underscores the challenges of translating early research into market-ready products.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

Temple’s study is a early but necessary step for health tech wearables, particularly those targeting brain monitoring. For founders, it underscores the importance of scientific validation in building trust with investors, regulators, and customers. The limitations of the study—such as its small sample size and preprint status—also serve as a reminder that premature claims can backfire, especially in sectors like health tech where credibility is critical. If Temple succeeds in further validation, it could signal growing maturity in India’s wearable health tech ecosystem, potentially attracting more capital to the space.

Key takeaways

• Temple’s validation study signals progress in wearable health tech, particularly for brain monitoring, a niche with growing investor interest in India.
• Founders in health tech wearables must prioritize scientific validation to build credibility, especially when targeting clinical or wellness applications.
• The study’s limitations—small sample size and lack of peer review—highlight the risks of early claims, which could impact investor or customer trust.